How long can you stay on semaglutide for weight loss?

You've been on it six months and it's working, now what?

This is the point where a lot of people start wondering whether they're supposed to stop. Six months feels like a milestone, and somewhere along the way many people have picked up the idea that these medicines are a short course, like antibiotics. They aren't. Semaglutide acts on appetite-regulating pathways in a way that requires ongoing presence to keep working. The biology doesn't change permanently after a set number of weeks.

Clinical trial data support longer use. The STEP 1 trial, published in the New England Journal of Medicine, ran for 68 weeks and found participants using semaglutide 2.4mg lost around 15% of their body weight on average, with the bulk of that loss continuing well past the first few months. When treatment was stopped in follow-up research, a substantial portion of the weight returned within about a year. That tells you something important: for many people, this is not a finite course with a natural end-point.

If your treatment is working and your prescriber is satisfied at each review, there is no clinical reason to stop on a fixed date. The question shifts from "how long?" to "how is it going?", something assessed at each clinical check-in.

The NICE two-year rule: what it actually means

NICE recommends semaglutide for a maximum of two years on the NHS, but that recommendation sits within a very specific context: it applies to treatment delivered through specialist weight management services, under the criteria set out in Technology Appraisal TA875. The two-year cap is an NHS commissioning decision tied to resource and pathway planning. It does not mean the medicine becomes unsafe or ineffective after two years, and it does not automatically apply to private treatment.

Private prescribing in the UK follows the medicine's licensed indications. Wegovy is licensed for weight management in adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition, alongside a reduced-calorie diet and increased physical activity. The licence does not include a time limit. A prescriber reviewing your private prescription will assess whether you are still benefiting, whether any concerns have arisen, and whether continuation is clinically appropriate, at every repeat. That review-at-every-step approach is how our clinical team at nume handles repeat orders: no automatic renewals, every prescription freshly considered.

It is worth knowing this distinction clearly, because a lot of the "you have to stop after two years" messaging online conflates NHS pathway rules with the licensed medicine itself. They are separate things.

What happens if you stop, and the question of long-term use

The honest answer is that stopping semaglutide usually leads to weight returning, often within months. This reflects the underlying biology of obesity: the appetite-signalling changes that the medicine supports do not persist when treatment ends. Research following STEP 1 participants after stopping found that around two-thirds of the weight lost was regained within a year of discontinuation.

This is not a failure of willpower or the treatment. Obesity is a chronic condition shaped by hormones, genetics, and environment, and managing it long-term is no different in principle from managing blood pressure or cholesterol with ongoing medication. Many people find the most effective approach is continued treatment, with their prescriber reviewing progress and dose regularly, and our page on how long you can use semaglutide goes into detail on what that ongoing use typically looks like. If you want a fuller picture of how results develop over time, our page on how long Wegovy takes to work covers the early weeks in more detail.

Stopping may be appropriate for some: if weight loss goals are met and sustained through lifestyle change, if side effects make continuing difficult, or if a prescriber judges that the benefit no longer outweighs any risks. Those are conversations that happen in clinical review, not decisions made unilaterally. If you're thinking through the costs and practicalities of staying on treatment longer term, it helps to understand how Wegovy is priced privately so you can plan realistically.

How prescribers assess whether to continue

At each repeat stage, a prescriber will typically consider a few things: how much weight you have lost, whether loss has stalled and for how long, whether you have reached your maintenance dose and tolerated it well, and whether any new health information changes the picture. The NHS guidance notes that if someone has not lost at least 5% of their body weight after six months on the maintenance dose, continuing is unlikely to be the right call. That benchmark applies in private practice too.

There is no single answer to how long treatment lasts, because it genuinely depends on the individual. Some people use semaglutide for a year and then taper off successfully, and if you are weighing up your own timeline our guide to how long you can take semaglutide walks through the factors that tend to shape that decision. Others find they need it for several years to maintain the gains they've made, and for those considering Wegovy specifically, our page on how long you can be on Wegovy covers what extended use looks like in practice. The prescriber's job is to help you work out which situation you're in. For a closer look at how duration compares across different semaglutide situations, the semaglutide treatment duration overview pulls together the key considerations in one place.

Semaglutide is a prescription-only medicine. If you are considering starting treatment, or you have questions about continuing it, a clinical assessment is where those answers come from, not a fixed rule. Start a free consultation and our prescribers can work through your specific circumstances with you.